Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
about
Progestational agents for treating threatened or established preterm labourProgestational agents for treating threatened or established preterm labourResistance to lipopolysaccharide-induced preterm delivery mediated by regulatory T cell function in micePreventing preterm birth with progesterone: costs and effects of screening low risk women with a singleton pregnancy for short cervical length, the Triple P studySimultaneous quantitation of 17alpha-hydroxyprogesterone caproate, 17alpha-hydroxyprogesterone and progesterone in human plasma using high-performance liquid chromatography-mass spectrometry (HPLC-MS/MS)The role of progesterone in prevention of preterm birth.Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome?Tocolysis for preterm labor: expert opinion.Parturition and recruitment of macrophages in cervix of mice lacking the prostaglandin F receptorProgesterone use after successful treatment of threatened pre-term delivery.Preconception care between pregnancies: the content of internatal care.Development and validation of a high-performance liquid chromatography-mass spectrometric assay for the determination of 17alpha-hydroxyprogesterone caproate (17-OHPC) in human plasma.Predicting Preterm Labour: Current Status and Future Prospects.Use and attitudes of obstetricians toward 3 high-risk interventions in MFMU Network hospitalsRecurrent preterm birth.Setting up a preterm prevention clinic: a practical guide.Emerging drug therapies for preventing spontaneous preterm labor and preterm birth.The management of preterm labour.Exploring heterogeneity in meta-analyses: needs, resources and challenges.Obstetric care after radical abdominal trachelectomy in a patient with stage IB1 cervical cancer: A case report and a review of medical literature.Progestational agents for the prevention of preterm birth.Progesterone supplementation for HIV-positive pregnant women on protease inhibitor-based antiretroviral regimens (the ProSPAR study): a study protocol for a pilot randomized controlled trialManagement of premature prelabor rupture of the membranes.Vaginal progesterone vs intramuscular 17α-hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth in singleton gestations: systematic review and meta-analysis of randomized controlled trials.Intravaginal use of natural micronised progesterone to prevent pre-term birth: a randomised trial in India.Cervical length compared to Bishop's score for prediction of pre-term birth in women with pre-term labour.Using 17 α-hydroxyprogesterone caproate to impact rates of recurrent preterm delivery in clinical practice.The role of 17 alpha-hydroxyprogesterone caproate in the prevention of preterm birth.Epidemiology of early pre-term delivery: relationship with clinical and histopathological infective parameters.Progesterone - induced blocking factor (PIBF) and Th(1)/Th(2) cytokine in women with threatened spontaneous abortion.Oral micronized progesterone for prevention of preterm birth.Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.Effects of progesterone and norethindrone on female fathead minnow (Pimephales promelas) steroidogenesis.Progesterone effects on preterm birth in high-risk pregnancies: a randomized placebo-controlled trial.Cervical pessaries for the prevention of preterm birth: a systematic review and meta-analysis.A national survey examining obstetrician perspectives on use of 17-alpha hydroxyprogesterone caproate post-US FDA approval.Efficacy of 17α-hydroxyprogesterone caproate in prevention of preterm delivery.Ability of a preterm surveillance clinic to triage risk of preterm birth: a prospective cohort study.Cervicovaginal HCG and cervical length for prediction of preterm delivery in asymptomatic women at high risk for preterm delivery.Resveratrol ameliorates prenatal progestin exposure-induced autism-like behavior through ERβ activation
P2860
Q24200891-57E4C2A6-3E7F-4E04-97A2-9398B87A8412Q24240588-211455A1-A1A5-496A-9501-59DB2813071BQ33583791-9EBEE658-6D7F-4D21-BB17-E5ADD61C4F5BQ34056744-1B67AC68-C693-45E4-833D-17C507901D86Q34069524-5F42AB87-063C-4EF7-9EEE-29581E771B74Q34271918-008F6546-37E6-48EB-BE33-D719C4110251Q34367437-016C2D38-7AEC-4C66-B062-D2FDC5D7A9C2Q34395388-3434BA49-8670-4A0D-B30A-53F57AD89356Q34543197-229B0929-20FA-4AD1-A8F6-C5CD14ABFCEAQ35017662-E539037D-ACEC-4BDD-A186-365A9A0A2DABQ35069417-39EFB9C3-674C-4EA4-A408-09573B9ACB0CQ35437948-2E4396FA-FED7-4BAF-A4D3-343A2A679AAFQ35800885-4D8F8AB2-32C9-4EEC-AA2F-3BB5FDD39DDEQ36016724-0AFA8DE9-AE88-4A4E-A8E9-D84C50B2957FQ36406581-08AF2159-816A-4C29-BCEE-5823B20CEE54Q36700879-023424F0-B568-49F4-A4FD-A1C36019B1BBQ36736352-10AC4CD9-E093-47A5-8F23-F09B9D88DB58Q36751536-D2F465E9-C0A4-4349-B7AA-BB9151B7F8F8Q37072917-F5BC7C2C-F94C-4032-9C79-361D2A9D3A89Q37158106-DDFAD16C-B6BA-40AB-A260-A42CFF2742A8Q37322420-56F14306-5A61-49E4-BA83-83CFB9C44C1DQ37498149-AE365A80-E817-4CB4-A9A2-C891A10194B3Q37788751-8F105351-E140-4D77-92E2-D7B67136E1D5Q38933403-53213C44-FB09-4F2D-9DEC-743730EA3DABQ39953556-61E463C9-CD3D-4B3D-82C7-43F8B16541FFQ39975682-4E8918AE-922B-4BEC-A579-F11C7CCE0351Q43156448-02414E1C-DE6D-4488-9B63-85BC9921FAB1Q43267030-66132727-4872-4657-B9E3-E6DD0A559C8CQ44073739-DABBA241-5A8D-4BF5-A3AB-51195A8C760DQ46086311-06E390C5-162D-4FD0-961D-9AF6A337DE24Q46311419-1DA20C8A-9C15-4F22-9C8B-D7366F73C8B9Q46315213-76B4D89C-776D-4BFF-B84C-22F18FA3537BQ46803490-AFA69AF3-84EB-4548-8AF4-C9331197082FQ46833418-E84CE00E-047F-428D-B539-1403328502C9Q50047486-31768FE6-9467-404F-9B4A-E1C39D9550B1Q50799671-40CAD451-14EC-48E6-B7DB-8903702CA5AAQ51034171-4784CEF1-AB6B-4680-B277-0201E7386B43Q51537718-767D79D2-C01F-4C19-B7EC-1D1F1868F983Q51823771-98A5C4D0-0442-4967-B2BF-6B493537859FQ58803233-1F29CACB-8BFC-418A-9C5B-C9756DB46BBF
P2860
Progestational agents to prevent preterm birth: a meta-analysis of randomized controlled trials.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Progestational agents to preve ...... randomized controlled trials.
@ast
Progestational agents to preve ...... randomized controlled trials.
@en
type
label
Progestational agents to preve ...... randomized controlled trials.
@ast
Progestational agents to preve ...... randomized controlled trials.
@en
prefLabel
Progestational agents to preve ...... randomized controlled trials.
@ast
Progestational agents to preve ...... randomized controlled trials.
@en
P2093
P1476
Progestational agents to preve ...... randomized controlled trials.
@en
P2093
Andrew M Kaunitz
Isaac Delke
Luis Sanchez-Ramos
P304
P356
10.1097/01.AOG.0000150559.59531.B2
P407
P577
2005-02-01T00:00:00Z